TRML - Tourmaline Bio, Inc.

Tourmaline Bio downgraded to Neutral from Buy at H.C. Wainwright

$48.00 (was $47.60)

Yi Chen · H.C. Wainwright

Sep 10, 2025 06:06 AM • TheFly

Tourmaline Bio downgraded to Neutral from Buy at Chardan

$48.00 (was $47.64)

Chardan Capital

Sep 09, 2025 04:09 PM • TheFly

Tourmaline Bio downgraded to Hold from Buy at Truist

$48.00 (was $47.64)

Srikripa Devarakonda · Truist Financial

Sep 09, 2025 04:07 PM • TheFly

Tourmaline Bio downgraded to Hold from Buy at Jefferies

$47.50 (was $47.64)

Jefferies

Sep 09, 2025 03:16 PM • TheFly

Tourmaline Bio downgraded to Neutral from Outperform at Wedbush

$48.00 (was $47.64)

Wedbush

Sep 09, 2025 07:09 AM • TheFly

Tourmaline Bio price target raised to $50 from $49 at H.C. Wainwright

$50.00 (was $18.80)

H.C. Wainwright

Mar 14, 2025 06:05 AM • TheFly

Tourmaline Bio initiated with an Outperform at Wedbush

$42.00 (was $14.33)

Wedbush

Mar 06, 2025 06:57 AM • TheFly

BMO Capital Starts Tourmaline Bio (TRML) at Outperform

$50.00 (was $24.03)

Etzer Darout · BMO Capital

Dec 05, 2024 04:12 PM • StreetInsider

Guggenheim reiterates Buy rating on Tourmaline Bio (TRML), "news is likely to increase investors' perceived risk"

$50.00 (was $28.61)

Yatin Suneja · Guggenheim

Mar 21, 2024 05:30 AM • StreetInsider

Tourmaline Bio (TRML) PT Raised to $74 at Truist Securities, 'have increased conviction for the opportunity for TOUR006'

$74.00 (was $44.67)

Robyn Karnauskas · Truist Financial

Mar 20, 2024 12:42 PM • StreetInsider

Tourmaline Bio (TRML) PT Raised to $72 at Jefferies

$72.00 (was $44.67)

Roger Song · Jefferies

Mar 20, 2024 12:37 AM • StreetInsider